Triple

T5160968
Position Surface form Disambiguated ID Type / Status
Subject Hodgkin lymphoma E116434 entity
Predicate hasSubtype P1244 FINISHED
Object lymphocyte-depleted classical Hodgkin lymphoma E116434 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: lymphocyte-depleted classical Hodgkin lymphoma | Statement: [Hodgkin lymphoma, hasSubtype, lymphocyte-depleted classical Hodgkin lymphoma]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: lymphocyte-depleted classical Hodgkin lymphoma
Context triple: [Hodgkin lymphoma, hasSubtype, lymphocyte-depleted classical Hodgkin lymphoma]
  • A. Hodgkin
    Hodgkin is a surname most famously associated with Dorothy Hodgkin, the Nobel Prize–winning British chemist who advanced the field of X-ray crystallography.
  • B. non-Hodgkin lymphoma
    Non-Hodgkin lymphoma is a diverse group of blood cancers that originate in the lymphatic system from abnormal lymphocytes and can vary widely in aggressiveness and prognosis.
  • C. Hodgkin lymphoma chosen
    Hodgkin lymphoma is a type of cancer that originates in the lymphatic system, characterized by the presence of abnormal Reed–Sternberg cells and often affecting lymph nodes.
  • D. Leukemia and Lymphoma Research
    Leukemia and Lymphoma Research is a UK-based medical research charity dedicated to improving the diagnosis, treatment, and prevention of blood cancers such as leukemia and lymphoma.
  • E. R-CHOP
    R-CHOP is a standard chemotherapy regimen combining rituximab with multiple cytotoxic drugs, commonly used to treat non-Hodgkin lymphoma.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69bd445edb3881909b93b34d260717fc completed March 20, 2026, 12:58 p.m.
NER Named-entity recognition batch_69bd79073a54819080cd1e8de6fe906a completed March 20, 2026, 4:42 p.m.
NED1 Entity disambiguation (via context triple) batch_69bed92b3ab48190900cf5c246dba433 completed March 21, 2026, 5:45 p.m.
Created at: March 20, 2026, 1:44 p.m.